Genomics

Dataset Information

0

Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/MAPK pathway

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE228025 | GEO | 2023/11/21

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/MAPK pathway [RNA-seq]
2023-11-21 | GSE228024 | GEO
Genomics Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/MAPK pathway [ChIP-seq]
2023-11-21 | GSE228023 | GEO
Unknown UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
| S-EPMC6511126 | biostudies-literature
Unknown SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.
| S-EPMC6421131 | biostudies-literature
Unknown Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling.
| S-EPMC4905428 | biostudies-other
Unknown MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
| S-EPMC6818206 | biostudies-literature
Unknown MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.
| S-EPMC5410235 | biostudies-literature
Unknown Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway.
| S-EPMC8206110 | biostudies-literature
Unknown Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
| S-EPMC3929873 | biostudies-other
Unknown Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
| S-EPMC7012480 | biostudies-literature